West Nile - Innovator

West Nile - Innovator® Manufacturer: Zoetis, Inc. This treatment applies to Horses West Nile Virus Vaccine Killed Virus For intramuscular vaccination of healthy horses 10 months of age or older as an aid in the prevention of viremia caused by West Nile Virus. Efficacy was demonstrated in horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile Virus. The vaccine protected 95% of the vaccinates against viremia, while 82% of the controls were viremic. Owners should be advised that vaccinated horses may develop antibody to West Nile Virus, which may affect their ability to export the animal. Dosage and Administration: Inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 6 weeks after the first dose. Revaccinate annually with one 1 mL dose. Caution: Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. Thimerosal, neomycin and polymyxin B added as preservatives. For Veterinary Use Only Remove Serial Number And Expiration Date Label And Place On The Animal's Medical Chart. Pfizer Animal Health, Exton, PA 19341, USA Div. Of Pfizer Inc, NY, NY 10017 U.S. Vet. License No. 189 Presentation: 1 mL: 1 Dose 10 mL: 10 Doses Nac No. 36903420 PFIZER INC. PFIZER ANIMAL HEALTH 235 E. 42ND ST., NEW YORK, NY, 10017 Telephone: 269-833-4000 Customer Service: 800-733-5500 and 800-793-0596 Veterinary Medical Investigations & Product Support: 800-366-5288 Technical Services (USA): 800-366-5288 This item is NON-RETURNABLE and NON-REFUNDABLE.